Sentinel Cerebral Protection System
GPTKB entity
Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:medical_device
|
| gptkbp:alternativeTo |
no protection during TAVR
|
| gptkbp:approvalYear |
2017
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:category |
cerebral embolic protection device
|
| gptkbp:clinicalTrialPhase |
SENTINEL trial
|
| gptkbp:focusArea |
embolic debris
|
| gptkbp:insertedBy |
gptkb:radial_artery
|
| gptkbp:manufacturer |
gptkb:Boston_Scientific
|
| gptkbp:marketedIn |
gptkb:Europe
gptkb:United_States |
| gptkbp:protectedBy |
brain
|
| gptkbp:reduces |
risk of periprocedural stroke
|
| gptkbp:usedDuring |
transcatheter aortic valve replacement
|
| gptkbp:usedFor |
stroke prevention
|
| gptkbp:bfsParent |
gptkb:Claret_Medical
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sentinel Cerebral Protection System
|